Stroke thrombolysis in a patient on dabigatran in the extended time window

N Z Med J. 2022 Jan 20;136(1568):105-108.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Antithrombins / adverse effects
  • Brain Ischemia* / drug therapy
  • Dabigatran / therapeutic use
  • Humans
  • New Zealand
  • Stroke* / drug therapy
  • Thrombolytic Therapy
  • Tissue Plasminogen Activator / therapeutic use

Substances

  • Dabigatran
  • Antithrombins
  • Tissue Plasminogen Activator